Keytruda 100 MG/4 ML vial 4ML
Ended Awarded
- Contract number
- SPE2DB25FYP76
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $32,758
Award facts
- Contract value 100% obligated
- $32,758.24 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $32,758.24 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Keytruda 100 mg/4 mL vials. This firm fixed-price delivery order, issued on August 12, 2025, with an ultimate completion date of September 3, 2025, represents a specific pharmaceutical procurement under DLA's broader medical supply operations. The contract carries no set-aside designation, allowing DMS Pharmaceutical Group to compete directly in the federal marketplace based on its established capabilities and pricing.
This delivery order is issued under DMS Pharmaceutical Group's existing Indefinite Delivery Contract with the Defense Logistics Agency valued at $499,999,999 through November 2026, which enables the agency to procure a comprehensive range of pharmaceutical products supporting military health facilities worldwide. As a woman-owned small business with over two decades of federal contracting experience, DMS Pharmaceutical Group has established itself as a critical supplier within the Department of Defense pharmaceutical supply chain, delivering prescription medications, biologics, and specialized medical products to government healthcare systems. The Keytruda delivery supports the DLA's mission to provide essential oncology treatments and other critical medications to military personnel and beneficiaries across the globe.
Quick answers
Who was awarded contract SPE2DB25FYP76?
SPE2DB25FYP76 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on August 12, 2025.
How much is contract SPE2DB25FYP76 worth?
The government has obligated $32,758 on SPE2DB25FYP76.
Is contract SPE2DB25FYP76 an order under another contract?
Yes. SPE2DB25FYP76 is a delivery order under SPE2DB22D9316, an indefinite delivery contract.
Was contract SPE2DB25FYP76 competed?
The extent of competition for SPE2DB25FYP76 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award